ORPHA:183669
Agammaglobulinemia
- Type
- Category
- Group
- Group of disorders
- Status
- active
This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.
1
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Agammaglobulinemia | |
| fr | Agammaglobulinémie | |
| de | Agammaglobulinämie | |
| es | Agammaglobulinemia | |
| it | Agammaglobulinemia | |
| nl | Agammaglobulinemie | |
| pt | Agamaglobulinemia | |
| pl | Agammaglobulinemia | |
| cs | Agamaglobulinémie | |
| uk | Агаммаглобулінемія | |
| zh | 丙种球蛋白缺乏血症 | |
| tr | Agamaglobulinemi |
2
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| MONDO | 0015977 | E | validated | |
| MONDO | 15977 | E | validated | |
| MeSH | D000361 | E | validated | |
| UMLS | C0001768 | E | validated | |
| MedDRA | 10001471 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
3
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:101977Immunodeficiency due to predominantly antibodies defect
rare genetic diseases; rare immunological diseases
4
Genes
0 directOrphanet records no gene directly on this code.
5
Prevalence and incidence
9 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Point prevalence | 1-9 / 1 000 000 | 0.13 / 100 000 | Europe | Value and class | Not yet validated | ORPHANET |
| Point prevalence | 1-9 / 1 000 000 | 0.287 / 100 000 | France | Value and class | Validated | 22288591[PMID] |
| Point prevalence | 1-9 / 1 000 000 | 0.134 / 100 000 | Spain | Value and class | Validated | 22288591[PMID] |
| Point prevalence | 1-9 / 1 000 000 | 0.192 / 100 000 | Netherlands | Value and class | Validated | 22288591[PMID] |
| Point prevalence | <1 / 1 000 000 | 0.045 / 100 000 | Turkey | Value and class | Validated | 22288591[PMID] |
| Point prevalence | <1 / 1 000 000 | 0.094 / 100 000 | United Kingdom | Value and class | Validated | 22288591[PMID] |
| Point prevalence | 1-9 / 1 000 000 | 0.205 / 100 000 | Italy | Value and class | Validated | 22288591[PMID] |
| Point prevalence | <1 / 1 000 000 | 0.077 / 100 000 | Germany | Value and class | Validated | 22288591[PMID] |
| Point prevalence | <1 / 1 000 000 | 0.071 / 100 000 | Poland | Value and class | Validated | 22288591[PMID] |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
6
HPO phenotypes
Orphanet has no HPO annotation for this code in this release.
7
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/183669
- This record as JSON: /data/d/183669.json